Controlled release from directly compressible theophylline buccal tablets

Colloids and Surfaces B: Biointerfaces

Volumn 77, Issue 2, 2010, Pages 227-233

  Boyapally, Harikrishna ^a   Nukala, Ravi Kumar ^a   Bhujbal, Pranav ^a   Douroumis, Dennis ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Bioadhesion; Buccal tablets; Controlled release; Direct compression; Kinetic models

Indexed keywords

ADHESIVE FORMULATION; BIO-ADHESION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; DETACHMENT FORCES; DIRECT COMPRESSION; EX-VIVO; GINGIVAL TISSUE; KINETIC MODELS; MUCOADHESION; MUCOADHESIVE POLYMERS; RELEASE MECHANISM; RELEASE PATTERN; SWELLING CAPACITIES; WATERSOLUBLE;

KINETIC THEORY; POLYMERS; RESINS; TENSILE STRENGTH;

POLYMORPHISM;

ALGINIC ACID; CARBOMER; HYDROXYPROPYLMETHYLCELLULOSE; POLYCARBOPHIL; POLYMER; POLYOX; RESIN; THEOPHYLLINE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DRUG CARRIER; TABLET;

ANIMAL TISSUE; ARTICLE; BUCCAL DRUG ADMINISTRATION; CONTROLLED RELEASE FORMULATION; EX VIVO STUDY; GINGIVA; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; TABLET COMPRESSION; TENSILE STRENGTH; ADHESION; ANIMAL; CHEEK; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; MATERIALS TESTING; PH; PHARMACOLOGY; SWINE; TABLET;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ANIMALS; CHEEK; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GINGIVA; HYDROGEN-ION CONCENTRATION; MATERIALS TESTING; POLYMERS; SWINE; TABLETS; TENSILE STRENGTH; THEOPHYLLINE;

SUS;

EID: 77950865748     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.01.031     Document Type: Article

References (40)

1. Ghosh T.K., Pfister W.R. Drug delivery to the oral cavity. Molecules to Market 2005, Taylor & Francis Group.
2. Bruschi M.L., Freitas O. Oral bioadhesive drug delivery systems. Drug Dev. Ind. Pharm. 2005, 31:293-310.
3. Madhav N.V., Shakya A.K., Shakya P., Singh K. Orotransmucosal drug delivery systems: a review. J. Control. Release 2009, 16:2-11.
4. Mizrahi B., Domb A.J. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat. Drug Deliv. Formul. 2008, 2:108-119.
5. Salamat-Miller N., Chittchang M., Johnston T.P. The use of mucoadhesive polymers in buccal drug delivery. J. Control. Release 2005, 57:1666-1691.
6. Wong C.F., Yuen K.H., Peh K.K. Formulation and evaluation of controlled release Eudragit buccal patches. Int. J. Pharm. 1999, 178:11-22.
7. Choi H., Jung J., Yong C.S., Rhee C., Lee M., Han J., Park K., Kim C. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J. Control. Release 2000, 68:405-412.
8. Choi H.G., Kim C.K. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J. Control. Release 2000, 68:397-404.
9. Singh B., Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev. Ind. Pharm. 2002, 28:431-442.
10. Jacobs M.H, Senior R.M., Kessler G. Clinical experience with theophylline. Relationships between dosage, serum concentration, and toxicity. JAMA 1977, 235:1983-1986.
11. Horai Y., Ishizaki T., Sasaki T., Chiba K., Suganuma T., Echizen H., Ohnishi A. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit I. Single dose study. Eur. J. Clin. Pharmacol. 1983, 24:79-87.
12. Parvez N., Ahmed T., Monif T., Saha N., Sharma P.L. Comparative bioavailability of three oral formulations of sustained release theophylline in healthy human subjects. Indian J. Pharmacol. 2004, 36:29-33.
13. Jug M., Bećirević-Laćan M. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci. 2004, 21:251-260.
14. Munasur A.P., Pillay V., Chetty D.J., Govender T. Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy. Int. J. Pharm. 2006, 323:43-51.
15. Giannola L.I., De Caro V., Giandalia G., Siragusa M.G., Tripodo C., Florena A.M., Campisi G. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. Eur. J. Pharm. Biopharm. 2007, 67:425-433.
16. Perioli L., Ambrogi V., Giovagnoli S., Ricci M., Blasi P., Rossi C. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAPS PharmSciTech 2007, 13:E54.
17. Geresh S., Gdalevsky G.Y., Gilboa I., Voorspoels J., Remon J.P., Kost J. Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release. J. Control. Release 2004, 94:391-399.
18. El-Samaligy M.S., Yahia S.A., Basalious E.B. Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int. J. Pharm. 2004, 286:27-39.
19. Yong C.S., Jung J.H., Rhee J.D., Kim C.K., Choi H.G. Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole. Drug Dev. Ind. Pharm. 2001, 27:447-455.
20. Maffei P., Lombardi Borgia S., Sforzini A., Yasin A., Ronchi C., Ceschel G.C. Design and in vitro-in vivo evaluation of bilaered tablet containing benzocaine for local buccal administration. J. Drug Deliv. Sci. Technol. 2004, 14:363-372.
21. Mortazavi S.A. An in vitro assessment of mucus/mucoadhesive interactions. Int. J. Pharm. 1995, 124:173-182.
22. Peppas N.A., Buri P.A. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release 1985, 2:257-275.
23. Ceschel G.C., Maffei P., Lombardi Borgia S., Ronchi C. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv. 2001, 8:161-171.
24. Fell J.T., Newton J.M. Determination of tablet strength by diametral-compression test. J. Pharm. Sci. 1970, 59:688-691.
25. Park C.R., Munday D.L. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int. J. Pharm. 2002, 237:215-226.
26. Eouani C., Piccerelle P., Prinderre P., Bourret E., Joachim J. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur. J. Pharm. Biopharm. 2001, 52:45-55.
27. Duchene D., Touchard F., Peppas N.A. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm. 1988, 14:283-318.
28. Nair M.K., Chien Y.W. Development of anticandidal deliverysystems: (II) mucoadhesive devices for prolonged drug delivery in the oral cavity. Drug Dev. Ind. Pharm. 1996, 22:243-253.
29. Mortazavi S.A., Smart J.D. Factors influencing gel-strengthening at the mucoadhesive-mucous interface. J. Pharm. Pharmacol. 1994, 46:86-90.
30. Ch'ng H.S., Park H., Kelly P., Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery. II. Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 1985, 74:399-405.
31. Ponchel G, Touchard F., Duchene D., Peppas N.A. Bioadhesive analysis of controlled release systems I. Fracture and interpenetration analysis in poly(acrylic acid) containing systems. J. Control. Release 1987, 5:129-141.
32. Peh K.K., Wong C.F. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J. Pharm. Pharmaceut. Sci. 1999, 2:53-61.
33. Costa P, Lobo J.M.S. Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2000, 13:123-133.
34. Kitazawa S., Johno I., Mihouchi T., Okada J. Interpretation of dissolution rate data from in vitro testing of compressed tablets. J. Pharm. Pharmacol. 1977, 29:453-459.
35. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
36. Siepmann J., Peppas N.A. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001, 48:139-157.
37. Varelas C.G., Dixon D.G., Steiner C. Zero-order release from biphasic polymer hydrogels. J. Control. Release 1995, 34:185-192.
38. Gibaldi M., Feldman S. Establishment of sink conditions in dissolution rate determinations. J. Pharm. Sci. 1967, 56:1238-1242.
39. Wagner J.G. Interpretation of percent dissolved-time plots derived form in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 18:1253-1257.
40. Yuksel N., Kanik A.E., Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 2000, 209:56-67.